Canada’s CGPA Installs New Leaders
Appoints New Chair And Vice-Chair From Pharmascience And Apotex
Canada’s off-patent industry association has looked to Pharmascience and Apotex for its new chair and vice-chair.
You may also be interested in...
Canadian policymakers must learn “difficult lessons” from the coronavirus pandemic and support measures to bolster domestic production and secure the country’s position as part of the global supply chain, according to CGPA president Jim Keon.
Aspen expects to report significant growth in its continuing operations for the first half of its financial year, following deals with Sandoz and Viatris that have seen the South African firm divest major businesses in Japan and Europe.
Medicines for Europe has called for fresh efforts to bolster the value added medicines sector and “level the playing field” with the US and its 505(b)(2) pathway, launching a new report setting out the three key areas in which greater EU action is needed.